BRIEF published on 01/21/2025 at 21:05, 1 year 7 months ago Fundraising of €0.25 million by Néovacs Fundraising Shareholder Dilution Néovacs OCEANE-BSA Kinoid® Research
BRIEF published on 01/21/2025 at 21:05, 1 year 7 months ago Levée de fonds de 0,25 M€ par Néovacs Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire Recherche Kinoïde®
PRESS RELEASE published on 01/21/2025 at 21:00, 1 year 7 months ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ par l'émission d'OCEANE-BSA pour financer la recherche sur les allergies et les investissements en BioTech et MedTech Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 01/15/2025 at 20:05, 1 year 7 months ago Adjustment of the nominal value at Neovacs Investment Capital Reduction Nominal Value Néovacs Stock Market Shares
BRIEF published on 01/15/2025 at 20:05, 1 year 7 months ago Ajustement de la valeur nominale chez Néovacs Investissement Valeur Nominale Néovacs Actions Boursières Réduction Capital
PRESS RELEASE published on 01/15/2025 at 20:00, 1 year 7 months ago Ajustement de la valeur nominale Néovacs réduit la valeur nominale de son action de 1 euro à 0,50 euro, suite à une réduction de capital motivée par des pertes. La société française développe des thérapies pour maladies inflammatoires Biopharmaceutique Réduction De Capital Maladies Inflammatoires Valeur Nominale Néovacs
BRIEF published on 12/18/2024 at 08:35, 1 year 8 months ago Levée de fonds par Néovacs Biotechnologie Levée De Fonds Dilution Néovacs OCEANE-BSA
BRIEF published on 12/18/2024 at 08:35, 1 year 8 months ago Fundraising by Neovacs Biotechnology Fundraising Dilution Néovacs OCEANE-BSA
PRESS RELEASE published on 12/18/2024 at 08:30, 1 year 8 months ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ pour financer le programme de recherche Kinoïde® sur les allergies et renforcer les investissements en BioTech et MedTech Biotech Levée De Fonds Néovacs Kinoïde® Allergies
BRIEF published on 09/18/2024 at 20:05, 1 year 11 months ago Fundraising of €0.25 million by Néovacs Biotechnology Fundraising Investment Dilution OCEANE-BSA
Published on 09/08/2026 at 15:40, 2 hours 51 minutes ago CANEX Increases Equity Financing to C$9 Million
Published on 09/08/2026 at 15:00, 3 hours 31 minutes ago Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Published on 09/08/2026 at 15:00, 3 hours 31 minutes ago Norsemont to Participate at Precious Metals Summit Beaver Creek
Published on 09/08/2026 at 14:30, 4 hours 1 minute ago Unusual Machines to Participate in Upcoming Investor Conferences
Published on 09/08/2026 at 14:30, 4 hours 1 minute ago Boron One Holdings Inc. - Jarandol Basin Exploration Program Update
Published on 09/08/2026 at 18:20, 11 minutes ago Rönesans Named Among the World's Top 50 International Contractors for the 11th Consecutive Year
Published on 09/08/2026 at 18:00, 31 minutes ago ARVERNE GROUP: Total number of shares and voting rights in the share capital as of August 31, 2026
Published on 09/08/2026 at 18:00, 31 minutes ago ARVERNE GROUP: Nombre total de droits de vote et d’actions composant le capital social au 31 août 2026
Published on 09/08/2026 at 17:40, 51 minutes ago LumApps Appoints Sébastien Cano as Chief Executive Officer
Published on 09/08/2026 at 17:45, 46 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 août 2026
Published on 09/08/2026 at 17:45, 46 minutes ago Chiffre d’affaires semestriel consolidé 2026 : 71,8 M€
Published on 09/08/2026 at 11:00, 7 hours 31 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 09/08/2026 at 11:00, 7 hours 31 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
